文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停复苏后同时调控动脉二氧化碳与动脉氧两个不同水平:一项随机先导试验

Targeting two different levels of both arterial carbon dioxide and arterial oxygen after cardiac arrest and resuscitation: a randomised pilot trial.
PubMed 文献 · Intensive Care Med · 2018-11-14
一句话结论院外心脏骤停复苏后,高正常PaCO2与中度高氧均升高NIRS值,但48小时NSE浓度未受影响。

该研究采用2×3析因设计,将123例院外心脏骤停复苏后患者随机分配至低正常PaCO2(4.5-4.7 kPa)或高正常PaCO2(5.8-6.0 kPa),以及正常氧(PaO2 10-15 kPa)或中度高氧(PaO2 20-25 kPa),同时分配至低正常或高正常平均动脉压。本文报告PaCO2与氧合两组比较结果。120例纳入分析,48小时NSE中位数在低正常PaCO2组为18.8 µg/l、高正常PaCO2组为22.5 µg/l(p=0.400),正常氧组为22.3 µg/l、中度高氧组为20.6 µg/l(p=0.594)。高正常PaCO2与中度高氧均升高NIRS值,其他次要终点无差异。结论为NSE浓度未受影响。

要点

  • 院外心脏骤停复苏后,低正常PaCO2(4.5-4.7 kPa)与高正常PaCO2(5.8-6.0 kPa)组48小时NSE中位数分别为18.8 µg/l与22.5 µg/l,p=0.400。
  • 正常氧(PaO2 10-15 kPa)与中度高氧(PaO2 20-25 kPa)组48小时NSE中位数分别为22.3 µg/l与20.6 µg/l,p=0.594。
  • 高正常PaCO2和中度高氧均升高NIRS值,但其他次要终点(S100B、肌钙蛋白、连续脑电图、6个月神经功能结局)无差异。
  • 两组间PaCO2(p<0.001)和PaO2(p<0.001)分离明显,说明目标值设置有效。

适用人群与场景

  • 院外心脏骤停(OHCA)复苏后收入ICU的患者,随机分组后前36小时在ICU内进行目标管理。

诊断标准与关键阈值

  • 低正常PaCO2目标:4.5-4.7 kPa;高正常PaCO2目标:5.8-6.0 kPa。
  • 正常氧目标:PaO2 10-15 kPa;中度高氧目标:PaO2 20-25 kPa。
  • 主要终点:心脏骤停后48小时血清神经元特异性烯醇化酶(NSE)浓度。

研究设计与关键结果

  • 研究类型:随机先导试验,采用2×3析因设计,123例随机分组,120例纳入分析。
  • 干预:低正常PaCO2(4.5-4.7 kPa)vs 高正常PaCO2(5.8-6.0 kPa);正常氧(PaO2 10-15 kPa)vs 中度高氧(PaO2 20-25 kPa);同时分配至低正常或高正常平均动脉压。
  • 主要终点:48小时NSE中位数低正常PaCO2组18.8 µg/l(IQR 13.9-28.3)vs 高正常PaCO2组22.5 µg/l(IQR 14.2-34.9),p=0.400;正常氧组22.3 µg/l(IQR 14.8-27.8)vs 中度高氧组20.6 µg/l(IQR 14.2-34.9),p=0.594。
  • 次要终点:高正常PaCO2和中度高氧均升高NIRS值;S100B蛋白、心肌肌钙蛋白、连续脑电图、6个月神经功能结局无差异。
  • 组间PaCO2分离p<0.001,PaO2分离p<0.001。

证据类型、等级与局限

  • 证据类型:随机先导试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在院外心脏骤停复苏后ICU患者中,将PaCO2控制在低正常(4.5-4.7 kPa)或高正常(5.8-6.0 kPa)范围、或PaO2控制在正常氧(10-15 kPa)或中度高氧(20-25 kPa)范围,对48小时NSE浓度无显著影响;高正常PaCO2与中度高氧升高NIRS值,但其他次要终点无差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: We assessed the effects of targeting low-normal or high-normal arterial carbon dioxide tension (PaCO2) and normoxia or moderate hyperoxia after out-of-hospital cardiac arrest (OHCA) on markers of cerebral and cardiac injury.

METHODS: Using a 23 factorial design, we randomly assigned 123 patients resuscitated from OHCA to low-normal (4.5-4.7 kPa) or high-normal (5.8-6.0 kPa) PaCO2 and to normoxia (arterial oxygen tension [PaO2] 10-15 kPa) or moderate hyperoxia (PaO2 20-25 kPa) and to low-normal or high-normal mean arterial pressure during the first 36 h in the intensive care unit. Here we report the results of the low-normal vs. high-normal PaCO2 and normoxia vs. moderate hyperoxia comparisons. The primary endpoint was the serum concentration of neuron-specific enolase (NSE) 48 h after cardiac arrest. Secondary endpoints included S100B protein and cardiac troponin concentrations, continuous electroencephalography (EEG) and near-infrared spectroscopy (NIRS) results and neurologic outcome at 6 months.

RESULTS: In total 120 patients were included in the analyses. There was a clear separation in PaCO2 (p < 0.001) and PaO2 (p < 0.001) between the groups. The median (interquartile range) NSE concentration at 48 h was 18.8 µg/l (13.9-28.3 µg/l) in the low-normal PaCO2 group and 22.5 µg/l (14.2-34.9 µg/l) in the high-normal PaCO2 group, p = 0.400; and 22.3 µg/l (14.8-27.8 µg/l) in the normoxia group and 20.6 µg/l (14.2-34.9 µg/l) in the moderate hyperoxia group, p = 0.594). High-normal PaCO2 and moderate hyperoxia increased NIRS values. There were no differences in other secondary outcomes.

CONCLUSIONS: Both high-normal PaCO2 and moderate hyperoxia increased NIRS values, but the NSE concentration was unaffected.

REGISTRATION: ClinicalTrials.gov, NCT02698917. Registered on January 26, 2016.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Jakkula P, Reinikainen M, Hästbacka J, et al. Targeting two different levels of both arterial carbon dioxide and arterial oxygen after cardiac arrest and resuscitation: a randomised pilot trial. Intensive Care Med. 2018. PMID: 30430209. doi:10.1007/s00134-018-5453-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。